These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 30886961)

  • 1. Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment.
    Jagpal A; Navarro-Millán I
    BMC Rheumatol; 2018; 2():10. PubMed ID: 30886961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis.
    DeMizio DJ; Geraldino-Pardilla LB
    Rheumatol Ther; 2020 Mar; 7(1):19-33. PubMed ID: 31853784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
    Naranjo A; Sokka T; Descalzo MA; Calvo-Alén J; Hørslev-Petersen K; Luukkainen RK; Combe B; Burmester GR; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Tunc R; Dimic A; Bergman M; Toloza S; Pincus T;
    Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
    Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
    Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?
    Day AL; Singh JA
    Drugs Aging; 2019 Jun; 36(6):493-510. PubMed ID: 30953327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study.
    Huang Y; Agarwal SK; Chatterjee S; Chen H; Johnson ML; Aparasu RR
    Clin Rheumatol; 2024 Jan; 43(1):103-116. PubMed ID: 37540382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
    van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
    Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
    Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
    Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis.
    Cho SK; Kim D; Won S; Lee J; Park B; Jang EJ; Bae SC; Sung YK
    Semin Arthritis Rheum; 2018 Feb; 47(4):501-506. PubMed ID: 28863826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Cardiovascular Disease Risk and Therapeutic Patterns among Urban Black Rheumatoid Arthritis Patients.
    McFarlane IM; Zhaz Leon SY; Bhamra MS; Burza A; Waite SA; Rodriguez Alvarez M; Koci K; Taklalsingh N; Kaplan I; Pathiparampil J; Kabani N; Watler E; Sorrento CS; Frefer M; Vaitkus V; Green J; Matthew K; Arroyo-Mercado F; Lyo H; Soliman F; Sanchez RA; Reyes FM; Ozeri DJ; Dronamraju V; Trevisonno M; Grant C; Clerger G; Amin K; Freeman L; Dawkins M; Lopez DL; Smerling J; Gondal I; Dellinger E; Paltoo K; Bhat H; Kolla S
    Med Sci (Basel); 2019 Feb; 7(2):. PubMed ID: 30791646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.
    Arts EE; Popa CD; Den Broeder AA; Donders R; Sandoo A; Toms T; Rollefstad S; Ikdahl E; Semb AG; Kitas GD; Van Riel PL; Fransen J
    Ann Rheum Dis; 2016 Apr; 75(4):674-80. PubMed ID: 25691119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of cardiovascular disease risk in patients with rheumatoid arthritis.
    Ahmed O; Krishnamurthy V; Kaba RA; Tahir H
    Expert Opin Pharmacother; 2022 Jun; 23(8):947-958. PubMed ID: 35575484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.
    Barbhaiya M; Solomon DH
    Curr Opin Rheumatol; 2013 May; 25(3):317-24. PubMed ID: 23466960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care.
    Weijers JM; Rongen-van Dartel SAA; Hoevenaars DMGMF; Rubens M; Hulscher MEJL; van Riel PLCM
    Ann Rheum Dis; 2018 Apr; 77(4):480-483. PubMed ID: 29167154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cardiovascular disease in rheumatoid arthritis.
    Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
    Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
    Giollo A; Bissell LA; Buch MH
    Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.
    Mackey RH; Kuller LH; Deane KD; Walitt BT; Chang YF; Holers VM; Robinson WH; Tracy RP; Hlatky MA; Eaton CB; Liu S; Freiberg MS; Talabi MB; Schelbert EB; Moreland LW
    Arthritis Rheumatol; 2015 Sep; 67(9):2311-22. PubMed ID: 25988241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
    Duruöz MT; Ataman Ş; Bodur H; Çay HF; Melikoğlu MA; Akgül Ö; Çapkın E; Gürer G; Çevik R; Göğüş FN; Kamanlı A; Yurdakul FG; Yağcı İ; Rezvani A; Altan L
    Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic Heart Disease and Rheumatoid Arthritis-Two Conditions, the Same Background.
    Rezuș E; Macovei LA; Burlui AM; Cardoneanu A; Rezuș C
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.
    Muhammed H; Misra DP; Jain N; Ganguly S; Pattanaik SS; Rai MK; Anuja AK; Mohindra N; Kumar S; Agarwal V
    Clin Rheumatol; 2022 Dec; 41(12):3675-3686. PubMed ID: 36006556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.